RSNA 2016

Abstract Archives of the RSNA, 2016


GI116-ED-X

Pancreatic Masses: The Weird and the Wild

All Day Room: GI Community, Learning Center



Luyao Shen, MD, Los Angeles, CA (Presenter) Nothing to Disclose
Taylor J. Choy, MD, Los Angeles, CA (Abstract Co-Author) Nothing to Disclose
Ely R. Felker, MD, Los Angeles, CA (Abstract Co-Author) Nothing to Disclose
Daniel J. Margolis, MD, Los Angeles, CA (Abstract Co-Author) Nothing to Disclose
David S. Lu, MD, Los Angeles, CA (Abstract Co-Author) Consultant, Medtronic, Inc Speaker, Medtronic, Inc Consultant, Johnson & Johnson Research Grant, Johnson & Johnson Consultant, Bayer AG Research Grant, Bayer AG Speaker, Bayer AG
Steven S. Raman, MD, Santa Monica, CA (Abstract Co-Author) Nothing to Disclose
Barbara M. Kadell, MD, Los Angeles, CA (Abstract Co-Author) Nothing to Disclose
TEACHING POINTS

1) To study the uncommon masses in the pancreas, which include rare path-proven lesions, weird presentations of common masses, and co-existent 2 or 3 separate pathologic entities in one pancreas.2) To study the complications of the pancreatic masses. 

TABLE OF CONTENTS/OUTLINE

1) Common masses gone wild: A) Main duct intraductal papillary mucinous neoplasm (IPMN) causing biliary dilatation. B) Multiple growing cysts: IPMN vs. mucinous cystic neoplasm on path. C) Solitary papillary epithelial neoplasm (SPEN) with widespread metastasis. D) Adenocarcinoma with drop pelvic metastasis.2) Rare path-proven masses: A) mixed acinar-endocrine carcinoma. B) myofibroblastic sarcoma. C) intraductal oncocytic papillary neoplasm (IOPN). D) multifocal acinar cell cystadenoma.3) Multiple entities in one pancreas: A) serous cystadenoma and IPMN. B) adenocarcinoma and IPMN. C) serous cystadenoma and adenocarcinoma. D) neuroendocrine, serous cystadenoma, and simple cysts in Von Hippel-Lindau (VHL)4) Secondary involvement: A) plasmacytoma. B) B-cell lymphoma. C) lung metastasis.